BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 36637054)

  • 1. Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias.
    Foong WC; Loh CK; Ho JJ; Lau DS
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD013767. PubMed ID: 36637054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias.
    Foong WC; Ho JJ; Loh CK; Viprakasit V
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011579. PubMed ID: 27755646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant supplementation for sickle cell disease.
    Bolarinwa AB; Oduwole O; Okebe J; Ogbenna AA; Otokiti OE; Olatinwo AT
    Cochrane Database Syst Rev; 2024 May; 5(5):CD013590. PubMed ID: 38775255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia.
    Padhani ZA; Gangwani MK; Sadaf A; Hasan B; Colan S; Alvi N; Das JK
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD011626. PubMed ID: 37975597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Rankine-Mullings AE; Nevitt SJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for chronic kidney disease in people with sickle cell disease.
    Roy NB; Carpenter A; Dale-Harris I; Dorée C; Estcourt LJ
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012380. PubMed ID: 37539955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fortification of condiments and seasonings with iron for preventing anaemia and improving health.
    Jalal CS; De-Regil LM; Pike V; Mithra P
    Cochrane Database Syst Rev; 2023 Sep; 9(9):CD009604. PubMed ID: 37665781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wheat flour fortification with iron for reducing anaemia and improving iron status in populations.
    Field MS; Mithra P; Estevez D; Peña-Rosas JP
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD011302. PubMed ID: 32677706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acupuncture and related interventions for the treatment of symptoms associated with carpal tunnel syndrome.
    Choi GH; Wieland LS; Lee H; Sim H; Lee MS; Shin BC
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011215. PubMed ID: 30521680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment for osteoporosis in people with beta-thalassaemia.
    Bhardwaj A; Swe KMM; Sinha NK
    Cochrane Database Syst Rev; 2023 May; 5(5):CD010429. PubMed ID: 37159055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deferasirox for managing iron overload in people with thalassaemia.
    Bollig C; Schell LK; Rücker G; Allert R; Motschall E; Niemeyer CM; Bassler D; Meerpohl JJ
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD007476. PubMed ID: 28809446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
    Weibel S; Rücker G; Eberhart LH; Pace NL; Hartl HM; Jordan OL; Mayer D; Riemer M; Schaefer MS; Raj D; Backhaus I; Helf A; Schlesinger T; Kienbaum P; Kranke P
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012859. PubMed ID: 33075160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
    Fisher SA; Brunskill SJ; Doree C; Gooding S; Chowdhury O; Roberts DJ
    Cochrane Database Syst Rev; 2013 Aug; (8):CD004450. PubMed ID: 23963793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise as adjunctive therapy for systemic lupus erythematosus.
    Frade S; O'Neill S; Greene D; Nutter E; Cameron M
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD014816. PubMed ID: 37073886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Wang WC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD003146. PubMed ID: 28094851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins for women with polycystic ovary syndrome not actively trying to conceive.
    Xiong T; Fraison E; Kolibianaki E; Costello MF; Venetis C; Kostova EB
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD008565. PubMed ID: 37462232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological agents for adults with acute respiratory distress syndrome.
    Lewis SR; Pritchard MW; Thomas CM; Smith AF
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD004477. PubMed ID: 31334568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.
    Wagner C; Griesel M; Mikolajewska A; Metzendorf MI; Fischer AL; Stegemann M; Spagl M; Nair AA; Daniel J; Fichtner F; Skoetz N
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD014963. PubMed ID: 36385229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.